In the contemporary age of scientific progress, chronic disease prevention has appeared to be more crucial and feasible than the restoration of health and medication. Therefore, this issue is believed to be addressed by the financial assistance of the government. I wholeheartedly concur with the notion for two reasons: the cost-effectiveness of investing in preventive measures and its positive influence on people’s life expectancy.
First and foremost, reducing the morbidity rate of preventable diseases should be the key reason why the government should allocate funds to many healthcare facilities, meaning that citizens are given an opportunity to have access to various healthcare monitoring strategies in order to track their health frequently and stably; hence, minimizing the chance of possible fatal chronic ailments. One instance to exemplify this is the fact that there is an increasing volume of vulnerable patients who are suffering from debilitating diseases, including diabetes, arthritis, heart diseases, and asthma over time in various developing countries comprising Vietnam. Not only does this miserably damaging health condition severely and consistently put their daily life into challenges in the long run, but it might also threaten their survival devastatingly due to the deficiency in hefty hospital treatments and personal financial restraints. Consequently, providing capital for designing effective disease prevention techniques seems to be less costly than financing medical regimens.
Another compelling incentive for the government to grant allowance to preventive healthcare is enhancing people’s life expectancy. Once the mortality rate from incurable illnesses can be lowered, people’s life spans can be considerably prolonged with more awareness of several deadly diseases. Take the development of vaccines and sophisticated medical procedures, particularly antibiotics as an example. These types of medicine have made an incredibly effective and efficient contribution to limiting the prevalence of diseases as well as sustaining human longevity globally.
In conclusion, the fact that the government subsidizes numerous holistic approaches to chronic ailment prevention has demonstrated the possible decline in the morbidity rate of fatal affliction and a growth in human lifetime. From my point of view, I believe preventive healthcare systems across the globe, considered in developed and developing countries, should receive more and more attention to bring the most prosperity to people’s health; as a result, this might also advance overall economic growth.